Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. EACPR/AHA Joint Scientific Statement

Authors Jonathan Meyers , Daniel Forman , Carl Lavie , Ross Arena , Viviane Conraads , Dalane Kitzman , Prof. Dr. Luc Vanhees , Marco Guazzi , Gerald Fletcher , Alessandro Mezzani , Volker Adams , Martin Halle
Published in European Heart Journal
Publication date 2012
Research groups Lifestyle and Health
Type Article

Summary

From an evidence-based perspective, cardiopulmonary exercise testing (CPX) is a well-supported assessment technique in both the United States (US) and Europe. The combination of standard exercise testing (ET) [i.e. progressive exercise provocation in association with serial electrocardiograms (ECGs), haemodynamics, oxygen saturation, and subjective symptoms] and measurement of ventilatory gas exchange amounts to a superior method to: (i) accurately quantify cardiorespiratory fitness (CRF), (ii) delineate the physiologic system(s) underlying exercise responses, which can be applied as a means to identify the exercise-limiting pathophysiological mechanism(s) and/or performance differences, and (iii) formulate function-based prognostic stratification. Cardiopulmonary ET certainly carries an additional cost as well as competency requirements and is not an essential component of evaluation in all patient populations. However, there are several conditions of confirmed, suspected, or unknown aetiology where the data gained from this form of ET is highly valuable in terms of clinical decision making.1

Language English
Published in European Heart Journal
Year and volume 2012 33
Page range 2917-2927

Algemeen